An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis



Status:Not yet recruiting
Conditions:Neurology, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:4/3/2019
Start Date:July 2019
End Date:March 2021
Contact:Momenta General Queries
Email:ClinicalTrialInfo@momentapharma.com
Phone:+1 617-491-9700

Use our guide to learn which trials are right for you!

An Open-label Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis

The purpose of this study is to evaluate the long-term safety and tolerability of M281 in
participants with generalized myasthenia gravis (gMG)


Participants must be ≥18 years of age with a documented history of Generalized Myasthenia
Gravis (gMG) and clinical signs/symptoms of gMG, not pregnant or breastfeeding, previously
participated in the MOM-281-004 study, had no major eligibility deviations or other major
protocol deviations or not met any of the stopping criteria or discontinued study drug in
the MOM-M281-004 study for any reason other than the need for rescue therapy as specified
in the MOM-M281-004 study.

Additional, more specific criteria are defined in the protocol.
We found this trial at
7
sites
Boca Raton, Florida 33487
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Cordova, Tennessee 38018
?
mi
from
Cordova, TN
Click here to add this to my saved trials
Durham, North Carolina 27710
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
London,
Click here to add this to my saved trials
Maitland, Florida 32751
?
mi
from
Maitland, FL
Click here to add this to my saved trials
Raleigh, North Carolina 27607
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Saint Petersburg, Florida 33713
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials